rediff.com

Search result for 'complicated urinary tract infections'

New Delhi, Jun 28...

Orchid Pharma & Cipla Partner for New Antibiotic in India

June 28, 2024 19:42
Orchid Pharma and Cipla collaborate to distribute Cefepime-Enmetazobactam, a new antibiotic for complicated infections, across India. The partnership aims to combat antimicrobial resistance and...

Read more »

New Delhi, Feb 26...

Cipla Gets CDSCO Approval for Plazomicin Antibiotic for Urinary Tract Infections

February 26, 2024 19:18
Cipla receives CDSCO approval for plazomicin, a new intravenous antibiotic for treating complicated urinary tract infections (CUTI), including pyelonephritis.

Read more »

New Delhi, Feb 23...

Orchid Pharma Gets USFDA Approval for UTI Drug

February 23, 2024 16:22
Orchid Pharma has received USFDA approval for Enmetazobactam, a new drug to treat complicated urinary tract infections. This marks a significant development in addressing global antimicrobial...

Read more »

New Delhi, Jan 30...

Orchid Pharma's New Antibiotic 'Exblifeb' Approved by EMA

January 30, 2024 12:52
Orchid Pharma's 'Exblifeb', featuring Enmetazobactam, a novel beta-lactamase inhibitor, receives EMA approval for treating UTIs, pneumonia, and bacteremia.

Read more »

TODAY'S MOST TRADED COMPANIES

  • Company Name
  • Price
  • Volume

More »

MORE NEWS

Navi Mumbai...
Navi Mumbai Airport ILS Signal Testing Begins

The Airports Authority of India (AAI) has begun ILS signal testing at the...
Air India VRS for...
Air India VRS for Non-Flying Staff Ahead of...

Air India has announced a voluntary retirement scheme (VRS) and voluntary separation...
Boon Raises USD 5...
Boon Raises USD 5 Million Funding Led by Roca...

Water technology startup Boon secures USD 5 million in funding led by Spanish Roca...

More »

Moneywiz Live!

ALL MONEYWIZ PAGES
rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback